Global Anti-Infective Vaccines Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Anti-Infective Vaccines Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Anti-Infective Vaccines by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Anti-Infective Vaccines by Country/Region, 2017, 2022 & 2028

2.2 Anti-Infective Vaccines Segment by Type

2.2.1 Inactivated Vaccines

2.2.2 Conjugate Vaccines

2.2.3 Live/attenuated Vaccines

2.3 Anti-Infective Vaccines Sales by Type

2.3.1 Global Anti-Infective Vaccines Sales Market Share by Type (2017-2022)

2.3.2 Global Anti-Infective Vaccines Revenue and Market Share by Type (2017-2022)

2.3.3 Global Anti-Infective Vaccines Sale Price by Type (2017-2022)

2.4 Anti-Infective Vaccines Segment by Application

2.4.1 Bacterial Diseases

2.4.2 Viral Diseases

2.5 Anti-Infective Vaccines Sales by Application

2.5.1 Global Anti-Infective Vaccines Sale Market Share by Application (2017-2022)

2.5.2 Global Anti-Infective Vaccines Revenue and Market Share by Application (2017-2022)

2.5.3 Global Anti-Infective Vaccines Sale Price by Application (2017-2022)

3 Global Anti-Infective Vaccines by Company

3.1 Global Anti-Infective Vaccines Breakdown Data by Company

3.1.1 Global Anti-Infective Vaccines Annual Sales by Company (2020-2022)

3.1.2 Global Anti-Infective Vaccines Sales Market Share by Company (2020-2022)

3.2 Global Anti-Infective Vaccines Annual Revenue by Company (2020-2022)

3.2.1 Global Anti-Infective Vaccines Revenue by Company (2020-2022)

3.2.2 Global Anti-Infective Vaccines Revenue Market Share by Company (2020-2022)

3.3 Global Anti-Infective Vaccines Sale Price by Company

3.4 Key Manufacturers Anti-Infective Vaccines Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Anti-Infective Vaccines Product Location Distribution

3.4.2 Players Anti-Infective Vaccines Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Anti-Infective Vaccines by Geographic Region

4.1 World Historic Anti-Infective Vaccines Market Size by Geographic Region (2017-2022)

4.1.1 Global Anti-Infective Vaccines Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Anti-Infective Vaccines Annual Revenue by Geographic Region

4.2 World Historic Anti-Infective Vaccines Market Size by Country/Region (2017-2022)

4.2.1 Global Anti-Infective Vaccines Annual Sales by Country/Region (2017-2022)

4.2.2 Global Anti-Infective Vaccines Annual Revenue by Country/Region

4.3 Americas Anti-Infective Vaccines Sales Growth

4.4 APAC Anti-Infective Vaccines Sales Growth

4.5 Europe Anti-Infective Vaccines Sales Growth

4.6 Middle East & Africa Anti-Infective Vaccines Sales Growth

5 Americas

5.1 Americas Anti-Infective Vaccines Sales by Country

5.1.1 Americas Anti-Infective Vaccines Sales by Country (2017-2022)

5.1.2 Americas Anti-Infective Vaccines Revenue by Country (2017-2022)

5.2 Americas Anti-Infective Vaccines Sales by Type

5.3 Americas Anti-Infective Vaccines Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Anti-Infective Vaccines Sales by Region

6.1.1 APAC Anti-Infective Vaccines Sales by Region (2017-2022)

6.1.2 APAC Anti-Infective Vaccines Revenue by Region (2017-2022)

6.2 APAC Anti-Infective Vaccines Sales by Type

6.3 APAC Anti-Infective Vaccines Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Anti-Infective Vaccines by Country

7.1.1 Europe Anti-Infective Vaccines Sales by Country (2017-2022)

7.1.2 Europe Anti-Infective Vaccines Revenue by Country (2017-2022)

7.2 Europe Anti-Infective Vaccines Sales by Type

7.3 Europe Anti-Infective Vaccines Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Anti-Infective Vaccines by Country

8.1.1 Middle East & Africa Anti-Infective Vaccines Sales by Country (2017-2022)

8.1.2 Middle East & Africa Anti-Infective Vaccines Revenue by Country (2017-2022)

8.2 Middle East & Africa Anti-Infective Vaccines Sales by Type

8.3 Middle East & Africa Anti-Infective Vaccines Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Anti-Infective Vaccines

10.3 Manufacturing Process Analysis of Anti-Infective Vaccines

10.4 Industry Chain Structure of Anti-Infective Vaccines

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Anti-Infective Vaccines Distributors

11.3 Anti-Infective Vaccines Customer

12 World Forecast Review for Anti-Infective Vaccines by Geographic Region

12.1 Global Anti-Infective Vaccines Market Size Forecast by Region

12.1.1 Global Anti-Infective Vaccines Forecast by Region (2023-2028)

12.1.2 Global Anti-Infective Vaccines Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Anti-Infective Vaccines Forecast by Type

12.7 Global Anti-Infective Vaccines Forecast by Application

13 Key Players Analysis

13.1 Emergent BioDefense Operations Lansing Inc.

13.1.1 Emergent BioDefense Operations Lansing Inc. Company Information

13.1.2 Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines Product Offered

13.1.3 Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Emergent BioDefense Operations Lansing Inc. Main Business Overview

13.1.5 Emergent BioDefense Operations Lansing Inc. Latest Developments

13.2 Sanofi Pasteur

13.2.1 Sanofi Pasteur Company Information

13.2.2 Sanofi Pasteur Anti-Infective Vaccines Product Offered

13.2.3 Sanofi Pasteur Anti-Infective Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Sanofi Pasteur Main Business Overview

13.2.5 Sanofi Pasteur Latest Developments

13.3 Merck & Co.

13.3.1 Merck & Co. Company Information

13.3.2 Merck & Co. Anti-Infective Vaccines Product Offered

13.3.3 Merck & Co. Anti-Infective Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Merck & Co. Main Business Overview

13.3.5 Merck & Co. Latest Developments

13.4 MedImmune LLC

13.4.1 MedImmune LLC Company Information

13.4.2 MedImmune LLC Anti-Infective Vaccines Product Offered

13.4.3 MedImmune LLC Anti-Infective Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 MedImmune LLC Main Business Overview

13.4.5 MedImmune LLC Latest Developments

13.5 Novartis Vaccines

13.5.1 Novartis Vaccines Company Information

13.5.2 Novartis Vaccines Anti-Infective Vaccines Product Offered

13.5.3 Novartis Vaccines Anti-Infective Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Novartis Vaccines Main Business Overview

13.5.5 Novartis Vaccines Latest Developments

13.6 Diagnostics Ltd.

13.6.1 Diagnostics Ltd. Company Information

13.6.2 Diagnostics Ltd. Anti-Infective Vaccines Product Offered

13.6.3 Diagnostics Ltd. Anti-Infective Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Diagnostics Ltd. Main Business Overview

13.6.5 Diagnostics Ltd. Latest Developments

13.7 Intercell Biomedical

13.7.1 Intercell Biomedical Company Information

13.7.2 Intercell Biomedical Anti-Infective Vaccines Product Offered

13.7.3 Intercell Biomedical Anti-Infective Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Intercell Biomedical Main Business Overview

13.7.5 Intercell Biomedical Latest Developments

13.8 MassBiologics

13.8.1 MassBiologics Company Information

13.8.2 MassBiologics Anti-Infective Vaccines Product Offered

13.8.3 MassBiologics Anti-Infective Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 MassBiologics Main Business Overview

13.8.5 MassBiologics Latest Developments

13.9 Barr Labs, Inc.

13.9.1 Barr Labs, Inc. Company Information

13.9.2 Barr Labs, Inc. Anti-Infective Vaccines Product Offered

13.9.3 Barr Labs, Inc. Anti-Infective Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Barr Labs, Inc. Main Business Overview

13.9.5 Barr Labs, Inc. Latest Developments

13.10 Organon Teknika Co.

13.10.1 Organon Teknika Co. Company Information

13.10.2 Organon Teknika Co. Anti-Infective Vaccines Product Offered

13.10.3 Organon Teknika Co. Anti-Infective Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Organon Teknika Co. Main Business Overview

13.10.5 Organon Teknika Co. Latest Developments

13.11 GlaxoSmithKline Biologicals

13.11.1 GlaxoSmithKline Biologicals Company Information

13.11.2 GlaxoSmithKline Biologicals Anti-Infective Vaccines Product Offered

13.11.3 GlaxoSmithKline Biologicals Anti-Infective Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 GlaxoSmithKline Biologicals Main Business Overview

13.11.5 GlaxoSmithKline Biologicals Latest Developments

13.12 CSL Ltd.

13.12.1 CSL Ltd. Company Information

13.12.2 CSL Ltd. Anti-Infective Vaccines Product Offered

13.12.3 CSL Ltd. Anti-Infective Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 CSL Ltd. Main Business Overview

13.12.5 CSL Ltd. Latest Developments

13.13 ID Biomedical Co.

13.13.1 ID Biomedical Co. Company Information

13.13.2 ID Biomedical Co. Anti-Infective Vaccines Product Offered

13.13.3 ID Biomedical Co. Anti-Infective Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 ID Biomedical Co. Main Business Overview

13.13.5 ID Biomedical Co. Latest Developments

13.14 Protein Sciences Co.

13.14.1 Protein Sciences Co. Company Information

13.14.2 Protein Sciences Co. Anti-Infective Vaccines Product Offered

13.14.3 Protein Sciences Co. Anti-Infective Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Protein Sciences Co. Main Business Overview

13.14.5 Protein Sciences Co. Latest Developments

13.15 Wyeth Pharmaceuticals, Inc.

13.15.1 Wyeth Pharmaceuticals, Inc. Company Information

13.15.2 Wyeth Pharmaceuticals, Inc. Anti-Infective Vaccines Product Offered

13.15.3 Wyeth Pharmaceuticals, Inc. Anti-Infective Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Wyeth Pharmaceuticals, Inc. Main Business Overview

13.15.5 Wyeth Pharmaceuticals, Inc. Latest Developments

13.16 Berna Biotech

13.16.1 Berna Biotech Company Information

13.16.2 Berna Biotech Anti-Infective Vaccines Product Offered

13.16.3 Berna Biotech Anti-Infective Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 Berna Biotech Main Business Overview

13.16.5 Berna Biotech Latest Developments

14 Research Findings and Conclusion

Table 1. Anti-Infective Vaccines Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Anti-Infective Vaccines Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Inactivated Vaccines

Table 4. Major Players of Conjugate Vaccines

Table 5. Major Players of Live/attenuated Vaccines

Table 6. Global Anti-Infective Vaccines Sales by Type (2017-2022) & (Units)

Table 7. Global Anti-Infective Vaccines Sales Market Share by Type (2017-2022)

Table 8. Global Anti-Infective Vaccines Revenue by Type (2017-2022) & ($ million)

Table 9. Global Anti-Infective Vaccines Revenue Market Share by Type (2017-2022)

Table 10. Global Anti-Infective Vaccines Sale Price by Type (2017-2022) & (US$/Unit)

Table 11. Global Anti-Infective Vaccines Sales by Application (2017-2022) & (Units)

Table 12. Global Anti-Infective Vaccines Sales Market Share by Application (2017-2022)

Table 13. Global Anti-Infective Vaccines Revenue by Application (2017-2022)

Table 14. Global Anti-Infective Vaccines Revenue Market Share by Application (2017-2022)

Table 15. Global Anti-Infective Vaccines Sale Price by Application (2017-2022) & (US$/Unit)

Table 16. Global Anti-Infective Vaccines Sales by Company (2020-2022) & (Units)

Table 17. Global Anti-Infective Vaccines Sales Market Share by Company (2020-2022)

Table 18. Global Anti-Infective Vaccines Revenue by Company (2020-2022) ($ Millions)

Table 19. Global Anti-Infective Vaccines Revenue Market Share by Company (2020-2022)

Table 20. Global Anti-Infective Vaccines Sale Price by Company (2020-2022) & (US$/Unit)

Table 21. Key Manufacturers Anti-Infective Vaccines Producing Area Distribution and Sales Area

Table 22. Players Anti-Infective Vaccines Products Offered

Table 23. Anti-Infective Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 24. New Products and Potential Entrants

Table 25. Mergers & Acquisitions, Expansion

Table 26. Global Anti-Infective Vaccines Sales by Geographic Region (2017-2022) & (Units)

Table 27. Global Anti-Infective Vaccines Sales Market Share Geographic Region (2017-2022)

Table 28. Global Anti-Infective Vaccines Revenue by Geographic Region (2017-2022) & ($ millions)

Table 29. Global Anti-Infective Vaccines Revenue Market Share by Geographic Region (2017-2022)

Table 30. Global Anti-Infective Vaccines Sales by Country/Region (2017-2022) & (Units)

Table 31. Global Anti-Infective Vaccines Sales Market Share by Country/Region (2017-2022)

Table 32. Global Anti-Infective Vaccines Revenue by Country/Region (2017-2022) & ($ millions)

Table 33. Global Anti-Infective Vaccines Revenue Market Share by Country/Region (2017-2022)

Table 34. Americas Anti-Infective Vaccines Sales by Country (2017-2022) & (Units)

Table 35. Americas Anti-Infective Vaccines Sales Market Share by Country (2017-2022)

Table 36. Americas Anti-Infective Vaccines Revenue by Country (2017-2022) & ($ Millions)

Table 37. Americas Anti-Infective Vaccines Revenue Market Share by Country (2017-2022)

Table 38. Americas Anti-Infective Vaccines Sales by Type (2017-2022) & (Units)

Table 39. Americas Anti-Infective Vaccines Sales Market Share by Type (2017-2022)

Table 40. Americas Anti-Infective Vaccines Sales by Application (2017-2022) & (Units)

Table 41. Americas Anti-Infective Vaccines Sales Market Share by Application (2017-2022)

Table 42. APAC Anti-Infective Vaccines Sales by Region (2017-2022) & (Units)

Table 43. APAC Anti-Infective Vaccines Sales Market Share by Region (2017-2022)

Table 44. APAC Anti-Infective Vaccines Revenue by Region (2017-2022) & ($ Millions)

Table 45. APAC Anti-Infective Vaccines Revenue Market Share by Region (2017-2022)

Table 46. APAC Anti-Infective Vaccines Sales by Type (2017-2022) & (Units)

Table 47. APAC Anti-Infective Vaccines Sales Market Share by Type (2017-2022)

Table 48. APAC Anti-Infective Vaccines Sales by Application (2017-2022) & (Units)

Table 49. APAC Anti-Infective Vaccines Sales Market Share by Application (2017-2022)

Table 50. Europe Anti-Infective Vaccines Sales by Country (2017-2022) & (Units)

Table 51. Europe Anti-Infective Vaccines Sales Market Share by Country (2017-2022)

Table 52. Europe Anti-Infective Vaccines Revenue by Country (2017-2022) & ($ Millions)

Table 53. Europe Anti-Infective Vaccines Revenue Market Share by Country (2017-2022)

Table 54. Europe Anti-Infective Vaccines Sales by Type (2017-2022) & (Units)

Table 55. Europe Anti-Infective Vaccines Sales Market Share by Type (2017-2022)

Table 56. Europe Anti-Infective Vaccines Sales by Application (2017-2022) & (Units)

Table 57. Europe Anti-Infective Vaccines Sales Market Share by Application (2017-2022)

Table 58. Middle East & Africa Anti-Infective Vaccines Sales by Country (2017-2022) & (Units)

Table 59. Middle East & Africa Anti-Infective Vaccines Sales Market Share by Country (2017-2022)

Table 60. Middle East & Africa Anti-Infective Vaccines Revenue by Country (2017-2022) & ($ Millions)

Table 61. Middle East & Africa Anti-Infective Vaccines Revenue Market Share by Country (2017-2022)

Table 62. Middle East & Africa Anti-Infective Vaccines Sales by Type (2017-2022) & (Units)

Table 63. Middle East & Africa Anti-Infective Vaccines Sales Market Share by Type (2017-2022)

Table 64. Middle East & Africa Anti-Infective Vaccines Sales by Application (2017-2022) & (Units)

Table 65. Middle East & Africa Anti-Infective Vaccines Sales Market Share by Application (2017-2022)

Table 66. Key Market Drivers & Growth Opportunities of Anti-Infective Vaccines

Table 67. Key Market Challenges & Risks of Anti-Infective Vaccines

Table 68. Key Industry Trends of Anti-Infective Vaccines

Table 69. Anti-Infective Vaccines Raw Material

Table 70. Key Suppliers of Raw Materials

Table 71. Anti-Infective Vaccines Distributors List

Table 72. Anti-Infective Vaccines Customer List

Table 73. Global Anti-Infective Vaccines Sales Forecast by Region (2023-2028) & (Units)

Table 74. Global Anti-Infective Vaccines Sales Market Forecast by Region

Table 75. Global Anti-Infective Vaccines Revenue Forecast by Region (2023-2028) & ($ millions)

Table 76. Global Anti-Infective Vaccines Revenue Market Share Forecast by Region (2023-2028)

Table 77. Americas Anti-Infective Vaccines Sales Forecast by Country (2023-2028) & (Units)

Table 78. Americas Anti-Infective Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)

Table 79. APAC Anti-Infective Vaccines Sales Forecast by Region (2023-2028) & (Units)

Table 80. APAC Anti-Infective Vaccines Revenue Forecast by Region (2023-2028) & ($ millions)

Table 81. Europe Anti-Infective Vaccines Sales Forecast by Country (2023-2028) & (Units)

Table 82. Europe Anti-Infective Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)

Table 83. Middle East & Africa Anti-Infective Vaccines Sales Forecast by Country (2023-2028) & (Units)

Table 84. Middle East & Africa Anti-Infective Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Global Anti-Infective Vaccines Sales Forecast by Type (2023-2028) & (Units)

Table 86. Global Anti-Infective Vaccines Sales Market Share Forecast by Type (2023-2028)

Table 87. Global Anti-Infective Vaccines Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 88. Global Anti-Infective Vaccines Revenue Market Share Forecast by Type (2023-2028)

Table 89. Global Anti-Infective Vaccines Sales Forecast by Application (2023-2028) & (Units)

Table 90. Global Anti-Infective Vaccines Sales Market Share Forecast by Application (2023-2028)

Table 91. Global Anti-Infective Vaccines Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 92. Global Anti-Infective Vaccines Revenue Market Share Forecast by Application (2023-2028)

Table 93. Emergent BioDefense Operations Lansing Inc. Basic Information, Anti-Infective Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 94. Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines Product Offered

Table 95. Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 96. Emergent BioDefense Operations Lansing Inc. Main Business

Table 97. Emergent BioDefense Operations Lansing Inc. Latest Developments

Table 98. Sanofi Pasteur Basic Information, Anti-Infective Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 99. Sanofi Pasteur Anti-Infective Vaccines Product Offered

Table 100. Sanofi Pasteur Anti-Infective Vaccines Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 101. Sanofi Pasteur Main Business

Table 102. Sanofi Pasteur Latest Developments

Table 103. Merck & Co. Basic Information, Anti-Infective Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 104. Merck & Co. Anti-Infective Vaccines Product Offered

Table 105. Merck & Co. Anti-Infective Vaccines Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 106. Merck & Co. Main Business

Table 107. Merck & Co. Latest Developments

Table 108. MedImmune LLC Basic Information, Anti-Infective Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 109. MedImmune LLC Anti-Infective Vaccines Product Offered

Table 110. MedImmune LLC Anti-Infective Vaccines Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 111. MedImmune LLC Main Business

Table 112. MedImmune LLC Latest Developments

Table 113. Novartis Vaccines Basic Information, Anti-Infective Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 114. Novartis Vaccines Anti-Infective Vaccines Product Offered

Table 115. Novartis Vaccines Anti-Infective Vaccines Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 116. Novartis Vaccines Main Business

Table 117. Novartis Vaccines Latest Developments

Table 118. Diagnostics Ltd. Basic Information, Anti-Infective Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 119. Diagnostics Ltd. Anti-Infective Vaccines Product Offered

Table 120. Diagnostics Ltd. Anti-Infective Vaccines Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 121. Diagnostics Ltd. Main Business

Table 122. Diagnostics Ltd. Latest Developments

Table 123. Intercell Biomedical Basic Information, Anti-Infective Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 124. Intercell Biomedical Anti-Infective Vaccines Product Offered

Table 125. Intercell Biomedical Anti-Infective Vaccines Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 126. Intercell Biomedical Main Business

Table 127. Intercell Biomedical Latest Developments

Table 128. MassBiologics Basic Information, Anti-Infective Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 129. MassBiologics Anti-Infective Vaccines Product Offered

Table 130. MassBiologics Anti-Infective Vaccines Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 131. MassBiologics Main Business

Table 132. MassBiologics Latest Developments

Table 133. Barr Labs, Inc. Basic Information, Anti-Infective Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 134. Barr Labs, Inc. Anti-Infective Vaccines Product Offered

Table 135. Barr Labs, Inc. Anti-Infective Vaccines Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 136. Barr Labs, Inc. Main Business

Table 137. Barr Labs, Inc. Latest Developments

Table 138. Organon Teknika Co. Basic Information, Anti-Infective Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 139. Organon Teknika Co. Anti-Infective Vaccines Product Offered

Table 140. Organon Teknika Co. Anti-Infective Vaccines Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 141. Organon Teknika Co. Main Business

Table 142. Organon Teknika Co. Latest Developments

Table 143. GlaxoSmithKline Biologicals Basic Information, Anti-Infective Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 144. GlaxoSmithKline Biologicals Anti-Infective Vaccines Product Offered

Table 145. GlaxoSmithKline Biologicals Anti-Infective Vaccines Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 146. GlaxoSmithKline Biologicals Main Business

Table 147. GlaxoSmithKline Biologicals Latest Developments

Table 148. CSL Ltd. Basic Information, Anti-Infective Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 149. CSL Ltd. Anti-Infective Vaccines Product Offered

Table 150. CSL Ltd. Anti-Infective Vaccines Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 151. CSL Ltd. Main Business

Table 152. CSL Ltd. Latest Developments

Table 153. ID Biomedical Co. Basic Information, Anti-Infective Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 154. ID Biomedical Co. Anti-Infective Vaccines Product Offered

Table 155. ID Biomedical Co. Anti-Infective Vaccines Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 156. ID Biomedical Co. Main Business

Table 157. ID Biomedical Co. Latest Developments

Table 158. Protein Sciences Co. Basic Information, Anti-Infective Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 159. Protein Sciences Co. Anti-Infective Vaccines Product Offered

Table 160. Protein Sciences Co. Anti-Infective Vaccines Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 161. Protein Sciences Co. Main Business

Table 162. Protein Sciences Co. Latest Developments

Table 163. Wyeth Pharmaceuticals, Inc. Basic Information, Anti-Infective Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 164. Wyeth Pharmaceuticals, Inc. Anti-Infective Vaccines Product Offered

Table 165. Wyeth Pharmaceuticals, Inc. Anti-Infective Vaccines Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 166. Wyeth Pharmaceuticals, Inc. Main Business

Table 167. Wyeth Pharmaceuticals, Inc. Latest Developments

Table 168. Berna Biotech Basic Information, Anti-Infective Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 169. Berna Biotech Anti-Infective Vaccines Product Offered

Table 170. Berna Biotech Anti-Infective Vaccines Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 171. Berna Biotech Main Business

Table 172. Berna Biotech Latest Developments

List of Figures

Figure 1. Picture of Anti-Infective Vaccines

Figure 2. Anti-Infective Vaccines Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Anti-Infective Vaccines Sales Growth Rate 2017-2028 (Units)

Figure 7. Global Anti-Infective Vaccines Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Anti-Infective Vaccines Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Inactivated Vaccines

Figure 10. Product Picture of Conjugate Vaccines

Figure 11. Product Picture of Live/attenuated Vaccines

Figure 12. Global Anti-Infective Vaccines Sales Market Share by Type in 2021

Figure 13. Global Anti-Infective Vaccines Revenue Market Share by Type (2017-2022)

Figure 14. Anti-Infective Vaccines Consumed in Bacterial Diseases

Figure 15. Global Anti-Infective Vaccines Market: Bacterial Diseases (2017-2022) & (Units)

Figure 16. Anti-Infective Vaccines Consumed in Viral Diseases

Figure 17. Global Anti-Infective Vaccines Market: Viral Diseases (2017-2022) & (Units)

Figure 18. Global Anti-Infective Vaccines Sales Market Share by Application (2017-2022)

Figure 19. Global Anti-Infective Vaccines Revenue Market Share by Application in 2021

Figure 20. Anti-Infective Vaccines Revenue Market by Company in 2021 ($ Million)

Figure 21. Global Anti-Infective Vaccines Revenue Market Share by Company in 2021

Figure 22. Global Anti-Infective Vaccines Sales Market Share by Geographic Region (2017-2022)

Figure 23. Global Anti-Infective Vaccines Revenue Market Share by Geographic Region in 2021

Figure 24. Global Anti-Infective Vaccines Sales Market Share by Region (2017-2022)

Figure 25. Global Anti-Infective Vaccines Revenue Market Share by Country/Region in 2021

Figure 26. Americas Anti-Infective Vaccines Sales 2017-2022 (Units)

Figure 27. Americas Anti-Infective Vaccines Revenue 2017-2022 ($ Millions)

Figure 28. APAC Anti-Infective Vaccines Sales 2017-2022 (Units)

Figure 29. APAC Anti-Infective Vaccines Revenue 2017-2022 ($ Millions)

Figure 30. Europe Anti-Infective Vaccines Sales 2017-2022 (Units)

Figure 31. Europe Anti-Infective Vaccines Revenue 2017-2022 ($ Millions)

Figure 32. Middle East & Africa Anti-Infective Vaccines Sales 2017-2022 (Units)

Figure 33. Middle East & Africa Anti-Infective Vaccines Revenue 2017-2022 ($ Millions)

Figure 34. Americas Anti-Infective Vaccines Sales Market Share by Country in 2021

Figure 35. Americas Anti-Infective Vaccines Revenue Market Share by Country in 2021

Figure 36. United States Anti-Infective Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 37. Canada Anti-Infective Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 38. Mexico Anti-Infective Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 39. Brazil Anti-Infective Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 40. APAC Anti-Infective Vaccines Sales Market Share by Region in 2021

Figure 41. APAC Anti-Infective Vaccines Revenue Market Share by Regions in 2021

Figure 42. China Anti-Infective Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 43. Japan Anti-Infective Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 44. South Korea Anti-Infective Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 45. Southeast Asia Anti-Infective Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 46. India Anti-Infective Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 47. Australia Anti-Infective Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 48. Europe Anti-Infective Vaccines Sales Market Share by Country in 2021

Figure 49. Europe Anti-Infective Vaccines Revenue Market Share by Country in 2021

Figure 50. Germany Anti-Infective Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 51. France Anti-Infective Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 52. UK Anti-Infective Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 53. Italy Anti-Infective Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 54. Russia Anti-Infective Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 55. Middle East & Africa Anti-Infective Vaccines Sales Market Share by Country in 2021

Figure 56. Middle East & Africa Anti-Infective Vaccines Revenue Market Share by Country in 2021

Figure 57. Egypt Anti-Infective Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 58. South Africa Anti-Infective Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 59. Israel Anti-Infective Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 60. Turkey Anti-Infective Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 61. GCC Country Anti-Infective Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 62. Manufacturing Cost Structure Analysis of Anti-Infective Vaccines in 2021

Figure 63. Manufacturing Process Analysis of Anti-Infective Vaccines

Figure 64. Industry Chain Structure of Anti-Infective Vaccines

Figure 65. Channels of Distribution

Figure 66. Distributors Profiles